Berman Capital Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Berman Capital Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$37K	Buy	622 +537	+632%	+$31.7K	0.01%	798
2021 Q2	$5K	Buy	85 +26	+44%	+$1.7K	﹤0.01%	1375
2021 Q1	$4K	Hold	59	–	–	﹤0.01%	1378
2020 Q4	$4K	Hold	59	–	–	﹤0.01%	1259
2020 Q3	$4K	Buy	59 +23	+64%	+$1.53K	﹤0.01%	1156
2020 Q2	$2K	Hold	36	–	–	﹤0.01%	1349
2020 Q1	$1K	Hold	36	–	–	﹤0.01%	1422
2019 Q4	$1K	Hold	36	–	–	﹤0.01%	1429
2019 Q3	$1K	Hold	36	–	–	﹤0.01%	1404
2019 Q2	$2K	Hold	36	–	–	﹤0.01%	1270
2019 Q1	$1K	Hold	36	–	–	﹤0.01%	1307
2018 Q4	$1K	Buy	+36	New	+$1.41K	﹤0.01%	1093

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Berman Capital Advisors's ARNA Position: Q3 2021 in Review

Berman Capital Advisors increased its Arena Pharmaceuticals Inc (ARNA) stake by 632% in Q3 2021, buying an estimated $31.7K and bringing the position to 622 shares worth $37K. The position accounts for 0.01% of the portfolio, ranked #798.

Berman Capital Advisors first reported a position in ARNA in Q4 2018 and has held it in 12 quarters since. 235 funds tracked by Wall St. Rank hold ARNA as of Q3 2021.

Berman Capital Advisors held 622 shares of Arena Pharmaceuticals Inc worth $37K as of Q3 2021.
Berman Capital Advisors bought 537 Arena Pharmaceuticals Inc shares in Q3 2021, an estimated $31.7K.
Arena Pharmaceuticals Inc made up 0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #798 holding.
Berman Capital Advisors first reported a position in Arena Pharmaceuticals Inc in Q4 2018 and has held it in 12 quarters since.
235 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.